CNNMoney.com »

Market Tracker

09/28 5:16pm ET

Dow
+116.07
33,666.34
+0.35%
S&P 500
+25.19
4,299.70
+0.59%
Nasdaq
+108.43
13,201.28
+0.83%
Russell 2000
+15.41
1,794.31
+0.87%
FTSE 100
0.00
7,601.85
0.00%
DAX
0.00
15,323.50
0.00%

AstraZeneca PLC (NASDAQ:AZN)

67.43

Delayed Data

As of Sep 28

-0.51 / -0.75%

Today’s Change

53.24

Today|||52-Week Range

76.56

-0.55%

Year-to-Date

Latest AZN News | Press Releases

Is it Time to Buy Pfizer, Moderna, or AstraZeneca's Stock? Sep 28 / Zacks.com - Paid Partner Content	CDC Recommends Pfizer's (PFE) RSV Jab to Protect Newborns Sep 25 / Zacks.com - Paid Partner Content
Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know Sep 28 / Zacks.com - Paid Partner Content	The Zacks Analyst Blog Highlights Pfizer, Merck and AstraZeneca Sep 25 / Zacks.com - Paid Partner Content
Ionis (IONS) Inks New Deal With Roche to Develop Novel RNA Drugs Sep 28 / Zacks.com - Paid Partner Content	3 Magnificent Growth Stocks to Buy Right Now Sep 24 / MotleyFool.com - Paid Partner Content
Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know Sep 27 / Zacks.com - Paid Partner Content	Pharma Stock Roundup: EU Nod to PFE's Litfulo, FDA Priority Tag to MRK Applications Sep 22 / Zacks.com - Paid Partner Content
Ionis (IONS) Meets Rare Disease Drug Study Goal, Stock Up 8.5% Sep 27 / Zacks.com - Paid Partner Content	Astrazeneca (AZN) Stock Moves -1.38%: What You Should Know Sep 21 / Zacks.com - Paid Partner Content
AstraZeneca PLC (AZN) Is a Trending Stock: Facts to Know Before Betting on It Sep 26 / Zacks.com - Paid Partner Content	CHMP Endorses AstraZeneca's (AZN) Enhertu in Lung Cancer Sep 18 / Zacks.com - Paid Partner Content
FDA Expands Lilly (LLY) Jardiance Label in Chronic Kidney Disease Sep 25 / Zacks.com - Paid Partner Content	Astrazeneca (AZN) Gains As Market Dips: What You Should Know Sep 15 / Zacks.com - Paid Partner Content
AstraZeneca's (AZN) Dato-DXd Meets Goal in Breast Cancer Study Sep 25 / Zacks.com - Paid Partner Content